Skip to main content
Erschienen in:

07.05.2022 | Research article

Impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients

verfasst von: Ibtissem Oueslati, Asma Kardi, Fatma Boukhayatia, Bassem Hammami, Meriem Cheikh, Neila Ben Romdhane, Moncef Feki, Meriem Yazidi, Melika Chihaoui

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to assess the impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients (T2D).

Methods

It was a prospective study including 55 T2D patients treated with oral hypoglycemic drugs, who intended to observe Ramadan fasting in 2019. All participants underwent a questionnaire, a physical examination, laboratory investigations, and a cardiovascular risk assessment using the Framingham score before Ramadan (T0), immediately after Ramadan (T1), and two months after Ramadan (T2).

Results

The mean age of participants was 54.5 ± 10.1 years. The number of fasted days was 29.3 ± 2.3 days. The mean total daily calorie intake decreased significantly by 19% during Ramadan (p < 10–3). A significant decrease in weight (79.8 ± 12.9 vs 78.4 ± 13.3 kg, p = 0.003), body mass index (29.8 ± 5.4 vs 29.2 ± 5.4 kg/m2, p = 0.004), waist circumference (98.2 ± 9.6 vs 96.3 ± 10.2 cm, p = 0.015), fat body mass (24.3 ± 9.4 vs 23.5 ± 9.7 kg, p = 0.043) was observed at T1. The weight loss was significantly correlated with the number of fasting days (r = 0.348, p = 0.009) and was maintained at T2. Serum fructosamine increased at T1 (303.6 ± 46 vs 333.49 ± 59.49 µmol/L, p < 10–3) and returned to its baseline levels at T2. A significant decrease in insulin (9.7 ± 5.5 vs 7.98 ± 5.05 mIU/L, p = 0.043), fibrinogen (3.7 ± 0.8 vs 3.4 ± 0.6 g/L, p = 0.003), and hs-CRP (4.8 ± 5.7 vs 3.7 ± 4.5 mg/L, p = 0.058) levels was observed at T1. Homocysteine level was significantly higher after Ramadan (12.2 ± 6.2 vs 13.5 ± 6.4 µmol/L, p = 0.001). However, no significant changes were found in blood pressure, fasting blood glucose, HOMA-IR, uric acid, lipids, and white blood cells count. The mean Framingham score decreased insignificantly after Ramadan.

Conclusions

Ramadan fasting in T2D patients seems to have a favorable impact on anthropometric parameters and inflammatory profile. However, it may cause a transient worsening of glycemic control.
Literatur
1.
Zurück zum Zitat Alarouj M, Assaadkhalil S, Buse J, Fahdil I, Fahmy M, Hafez S, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010;33(8):1895–902.CrossRef Alarouj M, Assaadkhalil S, Buse J, Fahdil I, Fahmy M, Hafez S, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010;33(8):1895–902.CrossRef
2.
Zurück zum Zitat Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.CrossRef Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.CrossRef
3.
Zurück zum Zitat Hassanein M, Al Sifri S, Shaikh S, Raza SA, Akram J, Pranoto A, et al. A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN. Diabetes Res Clin Pract. 2020;163:108154.CrossRef Hassanein M, Al Sifri S, Shaikh S, Raza SA, Akram J, Pranoto A, et al. A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN. Diabetes Res Clin Pract. 2020;163:108154.CrossRef
4.
Zurück zum Zitat Syed F, Arif MA, Ramzan A, Niazi R, Murtaza MI, Javed A. DAR-GRACE: Diabetes and Ramadan: glycaemic control, physician counselling and patient practices-experience from a tertiary care hospital in Pakistan. J Pak Med Assoc. 2020;70(11):1990–5.PubMed Syed F, Arif MA, Ramzan A, Niazi R, Murtaza MI, Javed A. DAR-GRACE: Diabetes and Ramadan: glycaemic control, physician counselling and patient practices-experience from a tertiary care hospital in Pakistan. J Pak Med Assoc. 2020;70(11):1990–5.PubMed
5.
Zurück zum Zitat Sahin SB, Ayaz T, Ozyurt N, Ilkkilic K, Kirvar A, Sezgin H. The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2013;121(9):531–4.CrossRef Sahin SB, Ayaz T, Ozyurt N, Ilkkilic K, Kirvar A, Sezgin H. The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2013;121(9):531–4.CrossRef
6.
Zurück zum Zitat Bouguerra R, Jabrane J, Maâtki C, Bensalem L, Hamzaoui J, Elkadhi A, et al. Lapratique du jeûne du mois de Ramadan chez le diabétique de type 2. Ann Endocrinol. 2006;67(1):54–9.CrossRef Bouguerra R, Jabrane J, Maâtki C, Bensalem L, Hamzaoui J, Elkadhi A, et al. Lapratique du jeûne du mois de Ramadan chez le diabétique de type 2. Ann Endocrinol. 2006;67(1):54–9.CrossRef
7.
Zurück zum Zitat Bener A, Alhamaq AOAA, Öztürk M, Çatan F, Haris PI, Rajput KU, et al. Effect of Ramadan fasting on glycemic control and other essential variables in diabetic patients. Ann Afr Med. 2018;17(4):196–202.CrossRef Bener A, Alhamaq AOAA, Öztürk M, Çatan F, Haris PI, Rajput KU, et al. Effect of Ramadan fasting on glycemic control and other essential variables in diabetic patients. Ann Afr Med. 2018;17(4):196–202.CrossRef
8.
Zurück zum Zitat Hassanein M, Alawadi FF, Elhadidy KES, Ali SS, Echtay A, Djaballah K, et al. The characteristics and pattern of care for the type 2 diabetes mellitus population in the Middle East and North Africa region during Ramadan: An international prospective study (DAR-MENA T2DM). Diabetes Res Clin Pract. 2019;151:275–84.CrossRef Hassanein M, Alawadi FF, Elhadidy KES, Ali SS, Echtay A, Djaballah K, et al. The characteristics and pattern of care for the type 2 diabetes mellitus population in the Middle East and North Africa region during Ramadan: An international prospective study (DAR-MENA T2DM). Diabetes Res Clin Pract. 2019;151:275–84.CrossRef
9.
Zurück zum Zitat Khaled MB, Belbraouet S. Ramadan fasting diet entailed a lipid metabolic disorder among type 2 diabetic obese women. Am J Appl Sci. 2009;6(3):471–7.CrossRef Khaled MB, Belbraouet S. Ramadan fasting diet entailed a lipid metabolic disorder among type 2 diabetic obese women. Am J Appl Sci. 2009;6(3):471–7.CrossRef
10.
Zurück zum Zitat Yeoh ECK, Zainudin SB, Loh WN, Chua CL, Fun S, Subramaniam T, et al. Fasting during Ramadan and associated changes in glycaemia, caloric intake and body composition with gender differences in singapore. Ann Acad Med Singapore. 2015;44(6):202–6.PubMed Yeoh ECK, Zainudin SB, Loh WN, Chua CL, Fun S, Subramaniam T, et al. Fasting during Ramadan and associated changes in glycaemia, caloric intake and body composition with gender differences in singapore. Ann Acad Med Singapore. 2015;44(6):202–6.PubMed
11.
Zurück zum Zitat Tiboura G, Khaled BM, Diaf M, Semeria S, Bouanani G. Effect of Ramadan fasting on serum glucose and lipid profile among algerian type 2 diabetes patients. Romanian J Diabetes Nut rMetab Dis. 2015;22(4):385–92.CrossRef Tiboura G, Khaled BM, Diaf M, Semeria S, Bouanani G. Effect of Ramadan fasting on serum glucose and lipid profile among algerian type 2 diabetes patients. Romanian J Diabetes Nut rMetab Dis. 2015;22(4):385–92.CrossRef
12.
Zurück zum Zitat M’guil M, Ragala MA, Elguessabi L, Fellat S, Chraibi A, Chabraoui L, et al. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control? Clin Exp Hypertens. 2008;30(5):339–57.CrossRef M’guil M, Ragala MA, Elguessabi L, Fellat S, Chraibi A, Chabraoui L, et al. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control? Clin Exp Hypertens. 2008;30(5):339–57.CrossRef
13.
Zurück zum Zitat Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the vector study. Curr Med Res Opin. 2011;27(7):1367–74.CrossRef Hassanein M, Hanif W, Malik W, Kamal A, Geransar P, Lister N, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the vector study. Curr Med Res Opin. 2011;27(7):1367–74.CrossRef
14.
Zurück zum Zitat Karatoprak C, Yolbas S, Cakirca M, Cinar A, Zorlu M, Kiskac M, et al. The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2013;17(18):2512–6.PubMed Karatoprak C, Yolbas S, Cakirca M, Cinar A, Zorlu M, Kiskac M, et al. The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2013;17(18):2512–6.PubMed
15.
Zurück zum Zitat Vasan SK, Karol R, Mahendri NV, Arulappan N, Jacob JJ, Thomas N. A prospective assessment of dietary patterns in muslim subjects with type 2 diabetes who undertake fasting during Ramadan. Indian J Endocrinol Metab. 2012;16(4):552.CrossRef Vasan SK, Karol R, Mahendri NV, Arulappan N, Jacob JJ, Thomas N. A prospective assessment of dietary patterns in muslim subjects with type 2 diabetes who undertake fasting during Ramadan. Indian J Endocrinol Metab. 2012;16(4):552.CrossRef
16.
Zurück zum Zitat Zargar AH, Siraj M, Jawa AA, Hasan M, Mahtab H. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract. 2010;64(8):1090–4.CrossRef Zargar AH, Siraj M, Jawa AA, Hasan M, Mahtab H. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract. 2010;64(8):1090–4.CrossRef
17.
Zurück zum Zitat Mnif F, Slama CB, Chaieb L, Blouza S, Hsairi M, Abid M. Observational study of the tunisian diabetic patients’ profile during the fasting of the holy month of Ramadan. J Endocrinol Diabetes. 2016;3(1):1–8. Mnif F, Slama CB, Chaieb L, Blouza S, Hsairi M, Abid M. Observational study of the tunisian diabetic patients’ profile during the fasting of the holy month of Ramadan. J Endocrinol Diabetes. 2016;3(1):1–8.
18.
Zurück zum Zitat Fernando HA, Zibellini J, Harris RA, Seimon RV, Sainsbury A. Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. 2019;11(2):278.CrossRef Fernando HA, Zibellini J, Harris RA, Seimon RV, Sainsbury A. Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. 2019;11(2):278.CrossRef
19.
Zurück zum Zitat Erdem Y, Özkan G, Ulusoy Ş, Arıcı M, Derici Ü, Şengül Ş, et al. Turkish Society of Hypertension and Renal Diseases. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. J Am Soc Hypertens. 2018;12(1):42–9.CrossRef Erdem Y, Özkan G, Ulusoy Ş, Arıcı M, Derici Ü, Şengül Ş, et al. Turkish Society of Hypertension and Renal Diseases. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. J Am Soc Hypertens. 2018;12(1):42–9.CrossRef
20.
Zurück zum Zitat Bener A, Yousafzai MT. Effect of Ramadan fasting on diabetes mellitus: a population-based study in Qatar. J Egyptian Public Health Associa. 2014;89(2):47–52.CrossRef Bener A, Yousafzai MT. Effect of Ramadan fasting on diabetes mellitus: a population-based study in Qatar. J Egyptian Public Health Associa. 2014;89(2):47–52.CrossRef
21.
Zurück zum Zitat Di Daniele N, Marrone G, Di Lauro M, Di Daniele F, Palazzetti D, Guerriero C, et al. Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction. Nutrients. 2021;13(1):274.CrossRef Di Daniele N, Marrone G, Di Lauro M, Di Daniele F, Palazzetti D, Guerriero C, et al. Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction. Nutrients. 2021;13(1):274.CrossRef
22.
Zurück zum Zitat Paul AK, Khan MA, Fariduddin M. Effect of Ramadan fasting on anthropometric measures and metabolic profiles among type 2 diabetic subjects. J Enam Med Coll. 2015;5(2):93–8.CrossRef Paul AK, Khan MA, Fariduddin M. Effect of Ramadan fasting on anthropometric measures and metabolic profiles among type 2 diabetic subjects. J Enam Med Coll. 2015;5(2):93–8.CrossRef
23.
Zurück zum Zitat Almulhem M, Susarla R, Alabdulaali L, Khunti K, Karamat MA, Rasiah T, et al. The effect of Ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: A systematic review. Diabetes Res Clin Pract. 2020;159:1–21.CrossRef Almulhem M, Susarla R, Alabdulaali L, Khunti K, Karamat MA, Rasiah T, et al. The effect of Ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: A systematic review. Diabetes Res Clin Pract. 2020;159:1–21.CrossRef
24.
Zurück zum Zitat Cornelissen G. Metabolic Syndrome, Adiponectin, Sleep, and the Circadian System. E Bio Med. 2018;33:20–1. Cornelissen G. Metabolic Syndrome, Adiponectin, Sleep, and the Circadian System. E Bio Med. 2018;33:20–1.
25.
Zurück zum Zitat Noh J. The effect of circadian and sleep disruptions on obesity risk. J Obes Met Synd. 2018;27(2):78.CrossRef Noh J. The effect of circadian and sleep disruptions on obesity risk. J Obes Met Synd. 2018;27(2):78.CrossRef
26.
Zurück zum Zitat Albrecht U. The circadian clock, metabolism and obesity. Obes Rev. 2017;18(1):25–33.CrossRef Albrecht U. The circadian clock, metabolism and obesity. Obes Rev. 2017;18(1):25–33.CrossRef
27.
Zurück zum Zitat Aravind SR, Khaled AT, Shaiful BI, Naim S, Ghaida K, Rose L, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin. 2011;27(6):1237–42.CrossRef Aravind SR, Khaled AT, Shaiful BI, Naim S, Ghaida K, Rose L, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin. 2011;27(6):1237–42.CrossRef
28.
Zurück zum Zitat Jabbar A, Hassanein M, Beshyah SA, Boye KS, Yu M, Babineaux SM. CREED study: hypoglycaemia during Ramadan in individuals with type 2 diabetes mellitus from three continents. Diabetes Res ClinPract. 2017;132:19–26.CrossRef Jabbar A, Hassanein M, Beshyah SA, Boye KS, Yu M, Babineaux SM. CREED study: hypoglycaemia during Ramadan in individuals with type 2 diabetes mellitus from three continents. Diabetes Res ClinPract. 2017;132:19–26.CrossRef
29.
Zurück zum Zitat Lee SWH, Lee JY, Tan CSS, Wong CP. Strategies to make Ramadan fasting safer in type 2 diabetics: a systematic review and network meta-analysis of randomized controlled trials and observational studies. Medicine. 2016;95(2):1–9. Lee SWH, Lee JY, Tan CSS, Wong CP. Strategies to make Ramadan fasting safer in type 2 diabetics: a systematic review and network meta-analysis of randomized controlled trials and observational studies. Medicine. 2016;95(2):1–9.
30.
Zurück zum Zitat McEwen LN, Ibrahim M, Ali NM, Assaad KSH, Tantawi HR, Nasr G, et al. Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan. BMJ Open Diabetes Res Care. 2015;3(1):1–8.CrossRef McEwen LN, Ibrahim M, Ali NM, Assaad KSH, Tantawi HR, Nasr G, et al. Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan. BMJ Open Diabetes Res Care. 2015;3(1):1–8.CrossRef
31.
Zurück zum Zitat Tourkmani AM, Hassali MA, Alharbi TJ, Alkhashan HI, Alobikan AH, Bakhiet AH, et al. Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes. Patient Prefer Adherence. 2016;10:1709–17.CrossRef Tourkmani AM, Hassali MA, Alharbi TJ, Alkhashan HI, Alobikan AH, Bakhiet AH, et al. Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes. Patient Prefer Adherence. 2016;10:1709–17.CrossRef
32.
Zurück zum Zitat Nematy M, AlinezhadNamaghi M, Rashed MM, Mozhdehifard M, Sajjadi SS, Akhlaghi S, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutr J. 2012;11:69.CrossRef Nematy M, AlinezhadNamaghi M, Rashed MM, Mozhdehifard M, Sajjadi SS, Akhlaghi S, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutr J. 2012;11:69.CrossRef
33.
Zurück zum Zitat Faris’ AE, Jahrami HA, Obaideen AA, Madkoure MI. Impact of diurnal intermittent fasting during Ramadan on inflammatory andoxidative stress markers in healthy people: Systematic review and meta-analysis. J Nutrition Interm Metab. 2019;15:18–26.CrossRef Faris’ AE, Jahrami HA, Obaideen AA, Madkoure MI. Impact of diurnal intermittent fasting during Ramadan on inflammatory andoxidative stress markers in healthy people: Systematic review and meta-analysis. J Nutrition Interm Metab. 2019;15:18–26.CrossRef
34.
Zurück zum Zitat Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016;39:S205–9.CrossRef Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016;39:S205–9.CrossRef
35.
Zurück zum Zitat Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21(5):1835.CrossRef Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21(5):1835.CrossRef
36.
Zurück zum Zitat Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, c-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann NutrMetab. 2007;51(1):88–95. Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, c-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann NutrMetab. 2007;51(1):88–95.
Metadaten
Titel
Impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients
verfasst von
Ibtissem Oueslati
Asma Kardi
Fatma Boukhayatia
Bassem Hammami
Meriem Cheikh
Neila Ben Romdhane
Moncef Feki
Meriem Yazidi
Melika Chihaoui
Publikationsdatum
07.05.2022
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2022
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-022-01046-8

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.